Alexis Technologies Revenue

About Alexis Technologies

Our Vision At Alexis Technologies, we are at the vanguard of revolutionizing drug safety evaluations. We envision a transformed landscape in both pharmaceutical and toxicology research, propelled by our state-of-the-art in-vitro inhalation models that faithfully replicate the in-vivo environment. By harnessing the capabilities of organ-on-chips, our objective is to forecast drugs' and toxins' responses in humans with unparalleled precision. As we pave this innovative path, our steadfast commitment remains clear: minimize the dependency on animal testing. Our Mission Alexis Technologies is dedicated to redefining standards in both pharmaceutical and toxicological research. Leveraging our unique organ-on-chip and in-vitro inhalation models, our mission is to deliver groundbreaking solutions that enhance preclinical evaluations' fidelity and accuracy. By doing so, we aim to streamline the drug and toxicant assessment process and ensure comprehensive safety profiles.

View contact profiles from Alexis Technologies